1. Home
  2. WVE vs AHL Comparison

WVE vs AHL Comparison

Compare WVE & AHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$13.40

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Aspen Insurance Holdings Limited Class A Ordinary Shares

AHL

Aspen Insurance Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$37.28

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
AHL
Founded
2012
2002
Country
Singapore
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.4B
IPO Year
2015
2025

Fundamental Metrics

Financial Performance
Metric
WVE
AHL
Price
$13.40
$37.28
Analyst Decision
Strong Buy
Buy
Analyst Count
16
8
Target Price
$29.94
$39.44
AVG Volume (30 Days)
4.0M
367.8K
Earning Date
03-03-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.46
EPS
N/A
6.60
Revenue
$109,230,000.00
$3,191,700,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.20
$7.73
P/E Ratio
N/A
$5.64
Revenue Growth
103.75
5.65
52 Week Low
$5.28
$27.05
52 Week High
$21.73
$37.38

Technical Indicators

Market Signals
Indicator
WVE
AHL
Relative Strength Index (RSI) 43.21 61.52
Support Level $13.22 $37.23
Resistance Level $14.51 $37.38
Average True Range (ATR) 1.33 0.11
MACD -0.38 -0.00
Stochastic Oscillator 3.18 65.62

Price Performance

Historical Comparison
WVE
AHL

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About AHL Aspen Insurance Holdings Limited Class A Ordinary Shares

Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.

Share on Social Networks: